Age-induced increase of leucine enkephalin enzyme degradation in human plasma

Peptides

Volumn 19, Issue 7, 1998, Pages 1155-1163

  Babst, Reto ^a   Bongiorno, Lucilla ^b   Marini, Mario ^b   Marzano, Marina ^b   Spagnoli, Giulio ^b   Roda, L Giorgio ^b   Urbani, Alessandra ^b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Aging; Enkephalins; Enzymes; Hydrolysis; Inhibitors; Plasma

Indexed keywords

ENZYME; INHIBITOR PROTEIN; LEUCINE ENKEPHALIN;

AGED; AGING; ARTICLE; CONTROLLED STUDY; ENZYME ASSAY; ENZYME DEGRADATION; FEMALE; HUMAN; HUMAN EXPERIMENT; HYDROLYSIS; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; THIN LAYER CHROMATOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; AGING; AMINOPEPTIDASES; ANALYSIS OF VARIANCE; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, THIN LAYER; ENKEPHALIN, LEUCINE; FEMALE; GLYCINE; HUMANS; HYDROLYSIS; KINETICS; MALE; MOLECULAR WEIGHT; PEPTIDE HYDROLASES; PROTEASE INHIBITORS; TYROSINE;

EID: 0032123520     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(98)00061-8     Document Type: Article

References (42)

1. Aronin N., Wiesen M., Liotta A.S., Schlussler G.C., Krieger D.T. Comparative metabolic clearance rates of β-endorphin and β-lipotropin in humans. Life Sci. 29:1981;1265-1269.
2. Ausiello C.M., Roda L.G. Leu-enkephalin binding to cultured human T lymphocytes. Cell Biol. Int. Reports. 8:1984;353-362.
3. Bidlack J.M., Saripalli L.D., Lawrence D.M.P. k- opioid binding sites on a murine lymphoma cell line. Eur. J. Pharmacol. 227:1992;257-265.
4. Bolacchi F., Marini M., Urbani A., Gilardi E., Roda L.G. Role of enzymes and inhibitors in leu-enkephalin metabolism in Oryctolagus and human plasma. Neurochem. Res. 21:1996;881-890.
5. Bolacchi F., Marini M., Urbani A., Roda L.G. Enzymes and inhibitors of leu-enkephalin metabolism in human plasma. Neurochem. Res. 20:1995;991-999.
6. Bowes M.A., Kenny A. J. An immunohistochemical study of endopeptidase-24.11 and aminopeptidase N in lymphoid tissues. Immunology. 60:1987;247-253.
7. Carr D.J.J., Serou M. Exogenous and endogenous opioids as biologic response modifiers. Immunopharmacology. 31:1995;59-71.
8. Caughey G.H., Leidig F., Viro N.F., Nadel J.A. Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase. J. Pharmacol. Exp. Ther. 244:1988;133-137.
9. Chipkin R.E., Coffin V.L. Analgesic and acute central nervous system side effects of the intravenously administered enkephalinase inhibitor SCH32615. Pharmacol. Biochem. Behav. 38:1991;21-27.
10. Connelly J.C., Skidgel R.A., Schultz W.W., Johnson A.R., Erdos E.G. Neutral endopeptidase 24.11 in human neutrophils: cleavage of chemotactic peptide. Proc. Natl. Acad. Sci. USA. 82:1985;8737-8741.
11. Daugè V., Mauborgne A., Casselin F., Fournie'-Zalusky M.-C., Roques B.-P. The dual peptidase inhibitor RB101 induces a long-lasting increase in the extracellular level of met-enkephalin-like material in the nucleus accumbens of freely moving rats. J. Neurochem. 67:1996;1301-1308.
12. Daynes R.A., Araneo B.A., Ershler W.B., Maloney C., Li G.-Z., Ryu S.-Y. Altered regulation of IL-6 production with normal aging. J. Immunol. 150:1993;5219-5230.
13. Drapeau G., Chow A., Ward P.E. Metabolism of bradykinin analogs by angiotensin I converting enzyme and carboxypeptidase N. Peptides. 12:1991;631-638.
14. Erdos E.G., Johnson A.R., Boyden N.T. Hydrolysis of enkephalins by cultured human endothelial cells and by purified peptidyl dipeptidase. Biochem. Pharmacol. 27:1978;843-848.
15. Gorenstein C., Snyder S.H. Two distinct enkephalinases solubilization, partial purification and separation from angiotensin converting enzyme . Life Sci. 25:1979;2065-2070.
16. Hambrook J.M., Morgan B.A., Rance M.J., Smith C.F. Mode of deactivation of the enkephalins by rat and human plasma and rat brain homogenates. Nature (London). 262:1976;782-783.
17. Hazum E., Chang K.-J., Cuatrecasas P. Specific non-opiate receptors for β-endorphin. Science (Washington DC). 205:1979;1033-1035.
18. + T cells from young and old mice. J. Immunol. 150:3602-3407; 1993.
19. Hucklebridge F.H., Hudspith B.N., Lydyard P.M., Brostoff J. Stimulation of human peripheral lymphocytes by methionine enkephalin and δ-selective opioid analogs. Immunopharmacology. 19:1990;87-91.
20. Katoh A., Nabeshima T., Kameyama T. Behavioral changes induced by stressful situations: effects of enkephalins, dynorphin, and their interactions. J. Pharmacol. Exp. Ther. 253:1990;600-607.
21. Kerr M.A., Kenny A.J. The purification and specificity of a neutral endopeptidase from rabbit kidney brush border. Biochem. J. 137:1974;477-488.
22. Laudenslager M.L., Ryan S.M., Drugan R.C., Hayson R.L., Mayer S.F. Coping and immunosuppression: inescapable but not escapable shock suppresses lymphocyte proliferation. Science (Washington DC). 221:1983;568-570.
23. Marini M., Roscetti G., Bongiorno L., Urbani A., Roda L.G. Hydrolysis and protection from hydrolysis of enkephalins in human plasma. Neurochem. Res. 5:1990;61-67.
24. Marini M., Urbani A., Bongiorno L., Roda L.G. Soluble enkephalin-degrading enzymes released by lymphemic and erythroleukemic cell lines. Neurochem. Res. 17:1992;1155-1161.
25. Marini M., Urbani A., Bongiorno L., Roda L.G. Interindividual variability of enkephalin-degrading enzymes in human plasma. Peptides. 18:1997;741-748.
26. McCain H.W., Bilotta J., Lamster I.B. Endorphinergic modulation of immune function: potent action of the dipeptide glycyl-L-glutamine. Life Sci. 41:1987;169-176.
27. Miller R.A. The aging immune system: primer and prospectus. Science (Washington DC). 273:1996;70-74.
28. Murasko D.M., Goonewardene I.M. T-cell function in aging mechanisms of decline . Ann. Rev. Gerontol. Geriatr. 10:1990;71-96.
29. Nieber K., Baumgarten C.R., Rathsak R., Furkert L., Oehme P., Kunkel G. Substance P and beta-endorphin-like immunoreactivity in lavage fluid of subjects with and without allergic asthma. J. Allergy Clin. Immunol. 90:1992;646-654.
30. Pierart M.E., Najdovski T., Appelboom T.E., Deschodt-Lanckman M.M. Effect of human endopeptidase 24.11 (enkephalinase) on IL-1-induced thymocyte proliferation activity. J. Immunol. 140:1988;3808-3811.
31. Plotnikoff N.P., Faith R.E., Murgo A.J., Herberman R.B., Good R.A. Methionine enkephalin a new cytokine - human studies . Clin. Immunol. Immunopathol. 82:1997;93-101.
32. Roda L.G., Bongiorno L., Trani E., Urbani A., Marini M. Positive and negative immunomodulation by opioid peptides. Int. J. Immunopharmacol. 18:1996;1-16.
33. Roda L.G., Venturelli F., Roscetti G. Hydrolysis and protection from the hydrolysis of circulating enkephalins. Comp. Biochem. Physiol. 85:(c):1987;449-454.
34. Roscetti G., Bongiorno L., Urbani A., Marini M., Roda L.G. Hydrolysis and binding of leucine enkephalin to lymphemic and erythroleukemic cell lines. Int. J. Immunopharmacol. 12:1990;391-396.
35. Roscetti G., Venturelli F., Roda L.G. Enkephalin- binding systems in human plasma III: comparative protection of different peptides. Neurochem Res. 13:1988;221-224.
36. Saksida L.M., Galea L.A.M., Kavaliers M. Antinociceptive effects of the enkephalinase inhibitor, SCH 34826, in the snail, Cepaea nemoralis. Peptides. 14:1993;763-765.
37. 1-31 on murine splenocyte proliferation via a naloxone-resistant receptor. Biochem. Biophys. Res. Commun. 3:1991;936-942.
38. Shaker M., Shahabi N.A., Sharp B.M. Expression of naloxone-resistant β-endorphin binding sites on A20 cells: effects of concanavalin A and dexamethasone. Immunopharmacology. 28:1994;183-192.
39. Schulteis G., Martinez J.L. Jr. Experience-dependent regulation of leu-enkephalin hydrolysis in rat plasma. Peptides. 14:1993;161-167.
40. Temussi P.A., Tancredi T., Pastore A., Castiglione- Morelli M.A. Experimental attempt to simulate receptor site environment. A 500-MHz 1H nuclear magnetic resonance study of enkephalin amides. Biochemistry. 26:1987;7856-7863.
41. van den Bergh P., Rozing J., Nagelkerken L. Identification of two moieties of β-endorphin with opposing effects on rat T-cell proliferation. Immunology. 79:1993;18-23.
42. 3H]β-endorphin in rat plasma is increased with chronic stress. Eur. J. Pharmacol. 16:1989;229-236.